Panbela Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 8
- Market Cap
- -
- Website
- http://www.panbela.com
Panbela Therapeutics Secures $12 Million Investment and Advances Clinical Programs
Panbela Therapeutics secured a $12 million financing commitment from Nant Capital to advance its clinical programs.
Panbela Therapeutics Initiates Phase I Trial of CPP-1X-S in STK11 Mutant NSCLC
Panbela Therapeutics has dosed the first patient in a Phase I trial evaluating CPP-1X-S (eflornithine sachets) in STK11 mutant non-small cell lung cancer (NSCLC).
© Copyright 2025. All Rights Reserved by MedPath